Latest Breaking News On - Inserm transfert initiative - Page 5 : comparemela.com

AELIS FARMA: Aelis Farma: Publication of the 2021 Annual Financial Report

Regulatory News: Aelis Farma (ISIN code: FR0014007ZB4 ticker: AELIS) (Paris: AELIS), a clinical-stage biopharmaceutical company specialized in the development of treatments for brain diseases (the

ODDO BHF Initiates the Coverage of Aelis Farma With a Buy Recommendation

Regulatory News: Aelis Farma (ISIN code: FR0014007ZB4 ticker: AELIS), a clinical-stage biopharmaceutical company specialized in the development of treatments for brain diseases (the Company »),

Aelis Farma Reports 2021 Annual Financial Results and Confirms Its 2022 Outlook

An exceptional fiscal year 2021, marked by positive phase 2a results for AEF0117, the recognition of the first sub-licensing revenues thanks to the signature of an industrial partnership with Indivior PLC, and securing major grants for AEF0217 (EU’s Horizon 2020 program) and AEF0117 (NIH-NIDA USA).A solid financial.

NovoBiome and Inserm form new collaboration to simulate human intestinal physiology

NovoBiome and Inserm form new collaboration to simulate

NovoBiome and Inserm form new collaboration to simulate human intestinal physiologyIntegration of Inserm’s leading technologies related to human stem.